Combination of entecavir/ peginterferon alfa-2a in children with HBeAg-positive immune tolerant chronic hepatitis B virus infection

The optimal management strategy for children with immune-tolerant chronic hepatitis B virus (HBV) infection remains unknown. The purpose of this clinical trial was to determine the safety and efficacy of therapy with entecavir and peginterferon in a group of children in the immune-tolerant phase of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hepatology
Auteurs principaux: Rosenthal, Philip, Ling, Simon C., Belle, Steven H., Murray, Karen F., Rodriguez-Baez, Norberto, Schwarzenberg, Sarah J., Teckman, Jeffrey, Lin, Hsing-Hua S., Schwarz, Kathleen B.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465180/
https://ncbi.nlm.nih.gov/pubmed/30318613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30312
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires